Screener/Healthcare/Biotechnology

CRNX

Crinetics Pharmaceuticals, Inc.NASDAQ
$35.86+1.51 (+4.39%)
Mid CapUnder $50HealthcareFastest GrowingLow Beta
$24.10
$57.99
$34.89
$36.00
EPS (TTM)$-4.94
P/E Ratio—
Dividend Yield—
Market Cap$3.63B
Volume33K
Prev Close$34.37
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$6.2M-$122.8M$-1.29—-1993.4%
Q3 '25$143K-$130.1M$-1.38—-90972.7%
Q2 '25$1.0M-$115.6M$-1.23—-11216.0%
Q1 '25$361K-$96.8M$-1.04—-26807.2%
Q3 '24$0-$76.8M$-0.96——
Q2 '24$399K-$74.1M$-0.94—-18560.2%
Q1 '24$640K-$66.9M$-0.93—-10457.8%
Q4 '23$0-$60.1M$-0.88——
Get Your Daily Market Recap